Market Trends of United Arab Emirates Drug Delivery Devices Industry
This section covers the major market trends shaping the UAE Drug Delivery Devices Market according to our research experts:
Oral Segment Expects to Register a High CAGR in the United Arab Emirates Drug Delivery Devices Market Over the Forecast Period
The oral segment is expected to witness significant growth in the United Arab Emirates delivery devices market over the forecast period. Oral-release drug delivery systems have received extensive attention owing to their flexibility, reduced dosing frequency, and better patient compliance.
The factors attributing to the growth of the market are the rising prevalence of chronic disease and the easy administration of drugs. For instance, in an article published in September 2021, researchers in the United Arab Emirates showed that combining polymers can significantly alter how the medication release pattern is controlled and prolonged. In addition, it has been observed that the matrix system comprising poloxamer188, hydroxypropyl methylcellulose, and stearyl alcohol is an effective one for regulating the release of diltiazem hydrochloride, which helps in treating hypertension and atrial fibrillation. This research is expected to increase the development of oral drug delivery devices for administering exact doses of drugs to patients suffering from hypertension and cardiovascular-related conditions, which is anticipated to fuel market growth.
Therefore, owing to the abovementioned factors, the studied segment is predicted to witness growth over the forecast period.
Injectable Segment is Expected to Have the Significant Market Share Over the Forecast Period
The injectable drugs segment is expected to grow over the forecast period owing to the factors such as the increasing number of chronic diseases, like cardiovascular disorders, diabetes, and cancer, and the growing demand for injectable drugs in the country.
In addition, the rising adult and aging population in the country are more prone to develop chronic diseases, which further raises the demand for effective drugs that can be administered safely and easily. This is anticipated to fuel market growth. For instance, according to 2022 statistics published by the UNPF, 83% of the population living in the United Arab Emirates is aged between 15 and 64 years, and 2% of the population is aged 65 and above.
The increasing drug approvals and company activities in developing injectable drugs are also contributing to the market growth. For instance, in October 2022, Hikma Pharmaceuticals launched Succinylcholine Chloride Injection in prefilled syringe (PFS) form, which is used for general anesthesia, to facilitate tracheal intubation, and to provide muscle relaxation during surgery or mechanical ventilation.
Therefore, owing to the factors mentioned above, the studied segment is predicted to witness growth over the forecast period.
